BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22102615)

  • 1. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
    Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
    Nephrol Dial Transplant; 2012 Jun; 27(6):2297-303. PubMed ID: 22102615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
    Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
    Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
    Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL; Chien KL; Lin SL; Chen YM; Tsai TJ; Wu KD
    Nephron Clin Pract; 2008; 109(3):c109-18. PubMed ID: 18663322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.
    Chang YT; Wu HL; Guo HR; Cheng YY; Tseng CC; Wang MC; Lin CY; Sung JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3588-95. PubMed ID: 21444362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure.
    Bosselmann H; Gislason G; Gustafsson F; Hildebrandt PR; Videbaek L; Kober L; Torp-Pedersen C; Tonder N; Rossing K; Christensen S; Kamper AL; Heaf J; Schou M
    Circ Heart Fail; 2013 Nov; 6(6):1124-31. PubMed ID: 24141097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
    Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
    Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study.
    Nag S; Bilous R; Kelly W; Jones S; Roper N; Connolly V
    Diabet Med; 2007 Jan; 24(1):10-7. PubMed ID: 17227319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA; Onuigbo NT
    Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of symptoms of depression with progression of CKD.
    Tsai YC; Chiu YW; Hung CC; Hwang SJ; Tsai JC; Wang SL; Lin MY; Chen HC
    Am J Kidney Dis; 2012 Jul; 60(1):54-61. PubMed ID: 22495469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.